Addiction isn’t just about substances. It’s about disconnection, from self, from others, from something greater.
In this conversation on The New Health Club podcast, Beond co-founders Tom Feegel and Talia Eisenberg share how psychedelics like ibogaine help us reconnect. To our inner truth. To each other. To the parts of us we thought were lost. They also dive into why ibogaine is gaining global attention.
They talk:
– The neuroscience of ibogaine’s reset
– PTSD, trauma, and the roots of addiction
– Why healing must include both clinical excellence and cultural reverence
– What it really means to feel safe in a treatment setting
This conversation delves into the science, cultural significance, and personal impact of Ibogaine therapy. If we rethink addiction treatment, could we finally turn the tide on the opioid crisis?
Watch here:
Key Takeaways from This Episode of The New Health Club podcast:
– Ibogaine is becoming more mainstream. Once an underground therapy, it’s now entering the public discourse.
– It offers real potential for addiction and PTSD treatment. Ibogaine works at a neurological level to reset brain chemistry and interrupt addictive patterns.
– Cultural and spiritual roots matter. Ibogaine isn’t just a treatment—it’s a profound experience with indigenous origins.
– Unlike other psychedelics, Ibogaine’s effects can last up to 48 hours. It’s intense, immersive, and deeply introspective.
– Healing is both clinical and spiritual. The best results come from clinics integrating modern medicine with ancient wisdom.
– Recovery is more than breaking addiction—it’s redefining identity. True healing requires personal growth, new perspectives, and community support.
– Addiction is often a symptom of deeper emotional pain or trauma. Addressing the root cause, not just the behavior, is essential.
– Peer-to-peer support is crucial. The recovery process is enhanced by those who have walked the same path.
Listen here:
After W. Bryan Hubbard’s powerful appearance on the Joe Rogan Experience, Beond saw a surge of interest—and it got me thinking: Could this be the moment when Ibogaine finally gets the recognition it deserves?
